Precision Medicine

Illumina Launches iHope Program Aimed at Identifying Undiagnosed Rare Diseases in Children

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced the iHope program, a philanthropic initiative aimed at identifying the genetic causes of undiagnosed rare diseases in children. With initial program partners Foundation for the Children of the Californias, Rare Genomics Institute, and UCSF Benioff Children’s Hospital San Francisco, selected patients in …

Read More »

Gene Discovered to Cause Rare, Severe Neurological Disorder

Researchers have linked a debilitating neurological disease in children to mutations in a gene that regulates neuronal development through control of protein movement within neuronal cells. The scientists from the Montreal Neurological Institute and Hospital at McGill University, led by Peter McPherson, along with collaborators in Saudi Arabia, Jordan, Germany, …

Read More »

Cardinal Health to Acquire Lymphoseek from Navidea for up to $310 Million

DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals (NYSE MKT: NAVB) today announced that it has entered into a definitive asset purchase agreement with Cardinal Health (NYSE: CAH). Pursuant to the purchase agreement, Cardinal Health will purchase Navidea’s Lymphoseek® product for lymphatic mapping, lymph node biopsy and the diagnosis of metastatic spread to lymph …

Read More »

Large-Scale Cancer Gene Profiling is Feasible but Faces Barriers

Researchers leading the largest genomic tumor profiling effort of its kind say such studies are technically feasible in a broad population of adult and pediatric patients with many different types of cancer, and that some patients can benefit by receiving precision drugs targeted to their tumors’ mutations or being enrolled …

Read More »

Bristol-Myers and Enterome Partner to Discover Microbiome-Based Therapeutics in Cancer

NEW YORK & PARIS–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) and Enterome, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, announced that they have entered into an Immuno-Oncology focused collaboration agreement for the discovery and development of microbiome-derived biomarkers, drug targets and bioactive molecules to be …

Read More »

Researchers Identify Protein Required for Breast Cancer Metastasis

Researchers have identified a new pathway and with it a protein, BRD4, necessary for breast cancer cells to spread. The findings, which appear in the journal Cancer Research, may provide a new target to suppress breast cancer metastasis. Triple-negative breast cancer is considered the worst subgroup of breast cancer. It …

Read More »

Roche Launches $100 Million Global Immunotherapy Research Network

Roche (SIX: RO, ROG; OTCQX: RHHBY) today launched the global cancer immunotherapy Centers of Research Excellence (imCORE™) Network. This network brings together many of the world’s leading scientific and clinical experts in cancer immunotherapy to collaborate in investigating the most promising new treatment approaches. The goal is to rapidly initiate …

Read More »

Tumor Cells in Blood Samples Could Predict Prostate Cancer Spread

Researchers have found a group of circulating tumor cells in prostate cancer patient blood samples which are linked to the spread of the disease, according to new research* presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool. This is the first time these cell types have been …

Read More »

WSU Researcher Develops Safer Gene Therapy

SPOKANE, Wash. – A Washington State University researcher has developed a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy. Grant Trobridge, an associate professor of pharmaceutical sciences, has altered the way a virus carries a beneficial gene to its target …

Read More »

MD Anderson-Led Study Develops Prediction Model for Lung Cancer Risk in Never Smokers

Researchers at The University of Texas MD Anderson Cancer Center have developed a new personalized assessment tool that could better predict lung cancer risk in never, light and heavy smokers using a large Taiwanese prospective cohort study. By incorporating risk factors in addition to smoking history, this tool could better …

Read More »